The global Glucuronolactone Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Powder, Liquid, Tablet/Capsule), By Application (Preservatives, Antioxidants, Processing Aids and Additives, Energy Supplements), By End-User (Food and Beverages, Pharmaceuticals, Others)
The global market for glucuronolactone in 2024 reflects a dynamic landscape characterized by rising consumer awareness regarding health and wellness, driving the demand for functional ingredients. Glucuronolactone, a naturally occurring compound found in various dietary supplements and energy drinks, has gained traction for its purported benefits in promoting detoxification, enhancing physical performance, and supporting overall vitality. This surge in demand is attributed to an increasingly health-conscious demographic seeking products that offer tangible health benefits. Furthermore, research and development initiatives focusing on exploring the therapeutic potential of glucuronolactone in areas such as liver health and cognitive function continue to contribute to market growth. Amidst evolving regulatory frameworks and shifting consumer preferences towards clean label and natural ingredients, stakeholders in the glucuronolactone market are poised to leverage innovation and strategic partnerships to capitalize on emerging opportunities.
The market report analyses the leading companies in the industry including Aadhunik Industries, Aceto US LLC, Anhui Fubore Pharmaceutical and Chemical Co. Ltd, Anmol Chemicals Group, Creative Compounds, Fengchen Group Co. Ltd, Foodchem International Corp, Hubei Yitai Pharmaceutical Co. Ltd, Jungbunzlauer Suisse AG, Merck KGaA, Newseed Chemical Co. Ltd, NutriScience Innovations LLC, Roquette Freres SA, Samex Overseas, Sancai Industry Co. Ltd, Shandong Baisheng Biotechnology Co. Ltd, Shandong Fuyuang Bio Tech Co. Ltd, Shandong Xinhong Pharmaceutical Co. Ltd, and Others.
A significant trend in the glucuronolactone market is the increasing demand for functional ingredients in food and beverage products. Consumers are becoming more health-conscious and seeking products that offer additional benefits beyond basic nutrition. Glucuronolactone, known for its potential health benefits such as supporting liver function and providing energy, is gaining traction as a functional ingredient in various food and beverage formulations. Manufacturers are incorporating glucuronolactone into energy drinks, dietary supplements, and functional beverages to cater to the growing consumer interest in products that promote overall health and well-being.
A key driver of the glucuronolactone market is the rising consumer awareness of health and wellness. As individuals increasingly prioritize health-conscious lifestyles, they are seeking products that align with their dietary preferences and wellness goals. Glucuronolactone, with its perceived health benefits and physiological effects, appeals to consumers looking for natural and functional ingredients to enhance their overall health and vitality. The growing emphasis on preventive healthcare and holistic well-being drives the demand for products containing glucuronolactone, thereby fueling the growth of the market.
An opportunity for growth in the glucuronolactone market lies in the expansion into new product categories and applications beyond traditional energy drinks. With increasing consumer interest in functional ingredients, there's potential to explore innovative formulations and applications for glucuronolactone in a diverse range of food and beverage products. For example, manufacturers can develop glucuronolactone-infused sports nutrition products, ready-to-drink beverages, functional snacks, and even beauty and skincare formulations. By leveraging the versatility of glucuronolactone and tapping into emerging consumer trends, companies can diversify their product portfolios, penetrate new market segments, and capitalize on the growing demand for functional ingredients in the food and beverage industry.
Within the Glucuronolactone market, the Powder segment stands out as the largest, owing to its versatile applications and ease of use. Powdered glucuronolactone offers convenience in formulation across various industries, including pharmaceuticals, dietary supplements, and functional foods. Its ability to dissolve easily in liquids makes it a preferred choice for manufacturers seeking to incorporate glucuronolactone into their products without compromising on texture or taste. Additionally, powdered form allows for precise dosing and blending, ensuring consistent product quality and efficacy. The growing demand for dietary supplements and energy drinks fortified with glucuronolactone further propels the dominance of the Powder segment, as consumers increasingly seek natural ingredients to support their health and wellness goals. Further, the shelf-stability and cost-effectiveness of powdered glucuronolactone make it an attractive option for manufacturers looking to optimize production processes and enhance product profitability. With its widespread adoption across diverse industries and its integral role in promoting overall health and vitality, the Powder segment maintains its stronghold as the largest segment within the Glucuronolactone market.
Among the segments delineated in the Glucuronolactone market, the Energy Supplements segment is the fastest-growing, driven by heightened consumer awareness of health and wellness, coupled with evolving lifestyle trends. Glucuronolactone, renowned for its potential to enhance energy levels and mental alertness, serves as a pivotal ingredient in energy supplements, attracting health-conscious consumers seeking natural alternatives to traditional stimulants. The increasing prevalence of hectic lifestyles, coupled with growing demands for sustained energy and cognitive function, fuels the exponential growth of energy supplements fortified with glucuronolactone. Further, endorsements by fitness enthusiasts and health influencers further propel consumer interest and uptake of these products. Additionally, the versatility of glucuronolactone allows for seamless integration into various formulations, including powders, beverages, and bars, catering to diverse consumer preferences and consumption habits. As the demand for natural energy-boosting solutions continues to escalate, driven by shifting consumer priorities and mounting concerns over synthetic additives, the Energy Supplements segment is poised for sustained expansion, solidifying its position as the fastest-growing segment within the Glucuronolactone market.
Among the segments delineated in the Glucuronolactone market by end-user, the Pharmaceuticals segment stands out as the largest and fastest-growing. This is primarily attributed to the escalating demand for pharmaceutical-grade glucuronolactone owing to its extensive applications in various medical formulations. Glucuronolactone, a naturally occurring compound, has garnered attention for its potential health benefits, including detoxification, liver support, and cognitive enhancement. With increasing consumer awareness regarding the importance of preventive healthcare and the rising prevalence of chronic diseases, pharmaceutical companies are incorporating glucuronolactone into their formulations, driving the segment's rapid growth. Further, the burgeoning pharmaceutical industry, coupled with ongoing research and development activities to explore novel therapeutic applications of glucuronolactone, further fuels the segment's expansion. Consequently, the Pharmaceuticals segment is the dominant force in the Glucuronolactone market, poised for sustained growth in the foreseeable future.
By Type
Powder
Liquid
Tablet/Capsule
By Application
Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements
By End-User
Food and Beverages
Pharmaceuticals
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Aadhunik Industries
Aceto US LLC
Anhui Fubore Pharmaceutical and Chemical Co. Ltd
Anmol Chemicals Group
Creative Compounds
Fengchen Group Co. Ltd
Foodchem International Corp
Hubei Yitai Pharmaceutical Co. Ltd
Jungbunzlauer Suisse AG
Merck KGaA
Newseed Chemical Co. Ltd
NutriScience Innovations LLC
Roquette Freres SA
Samex Overseas
Sancai Industry Co. Ltd
Shandong Baisheng Biotechnology Co. Ltd
Shandong Fuyuang Bio Tech Co. Ltd
Shandong Xinhong Pharmaceutical Co. Ltd
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Glucuronolactone Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Glucuronolactone Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Glucuronolactone Market Share by Company, 2023
4.1.2. Product Offerings of Leading Glucuronolactone Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Glucuronolactone Market Drivers
6.2. Glucuronolactone Market Challenges
6.6. Glucuronolactone Market Opportunities
6.4. Glucuronolactone Market Trends
Chapter 7. Global Glucuronolactone Market Outlook Trends
7.1. Global Glucuronolactone Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Glucuronolactone Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Glucuronolactone Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Powder
Liquid
Tablet/Capsule
By Application
Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements
By End-User
Food and Beverages
Pharmaceuticals
Others
Chapter 8. Global Glucuronolactone Regional Analysis and Outlook
8.1. Global Glucuronolactone Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Glucuronolactone Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Glucuronolactone Regional Analysis and Outlook
8.2.2. Canada Glucuronolactone Regional Analysis and Outlook
8.2.3. Mexico Glucuronolactone Regional Analysis and Outlook
8.3. Europe Glucuronolactone Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Glucuronolactone Regional Analysis and Outlook
8.3.2. France Glucuronolactone Regional Analysis and Outlook
8.3.3. United Kingdom Glucuronolactone Regional Analysis and Outlook
8.3.4. Spain Glucuronolactone Regional Analysis and Outlook
8.3.5. Italy Glucuronolactone Regional Analysis and Outlook
8.3.6. Russia Glucuronolactone Regional Analysis and Outlook
8.3.7. Rest of Europe Glucuronolactone Regional Analysis and Outlook
8.4. Asia Pacific Glucuronolactone Revenue (USD Million) by Country (2021-2032)
8.4.1. China Glucuronolactone Regional Analysis and Outlook
8.4.2. Japan Glucuronolactone Regional Analysis and Outlook
8.4.3. India Glucuronolactone Regional Analysis and Outlook
8.4.4. South Korea Glucuronolactone Regional Analysis and Outlook
8.4.5. Australia Glucuronolactone Regional Analysis and Outlook
8.4.6. South East Asia Glucuronolactone Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Glucuronolactone Regional Analysis and Outlook
8.5. South America Glucuronolactone Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Glucuronolactone Regional Analysis and Outlook
8.5.2. Argentina Glucuronolactone Regional Analysis and Outlook
8.5.3. Rest of South America Glucuronolactone Regional Analysis and Outlook
8.6. Middle East and Africa Glucuronolactone Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Glucuronolactone Regional Analysis and Outlook
8.6.2. Africa Glucuronolactone Regional Analysis and Outlook
Chapter 9. North America Glucuronolactone Analysis and Outlook
9.1. North America Glucuronolactone Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Glucuronolactone Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Glucuronolactone Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Glucuronolactone Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Tablet/Capsule
By Application
Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements
By End-User
Food and Beverages
Pharmaceuticals
Others
Chapter 10. Europe Glucuronolactone Analysis and Outlook
10.1. Europe Glucuronolactone Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Glucuronolactone Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Glucuronolactone Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Glucuronolactone Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Tablet/Capsule
By Application
Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements
By End-User
Food and Beverages
Pharmaceuticals
Others
Chapter 11. Asia Pacific Glucuronolactone Analysis and Outlook
11.1. Asia Pacific Glucuronolactone Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Glucuronolactone Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Glucuronolactone Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Glucuronolactone Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Tablet/Capsule
By Application
Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements
By End-User
Food and Beverages
Pharmaceuticals
Others
Chapter 12. South America Glucuronolactone Analysis and Outlook
12.1. South America Glucuronolactone Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Glucuronolactone Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Glucuronolactone Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Glucuronolactone Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Tablet/Capsule
By Application
Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements
By End-User
Food and Beverages
Pharmaceuticals
Others
Chapter 13. Middle East and Africa Glucuronolactone Analysis and Outlook
13.1. Middle East and Africa Glucuronolactone Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Glucuronolactone Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Glucuronolactone Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Glucuronolactone Revenue (USD Million) by Product (2021-2032)
By Type
Powder
Liquid
Tablet/Capsule
By Application
Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements
By End-User
Food and Beverages
Pharmaceuticals
Others
Chapter 14. Glucuronolactone Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Aadhunik Industries
Aceto US LLC
Anhui Fubore Pharmaceutical and Chemical Co. Ltd
Anmol Chemicals Group
Creative Compounds
Fengchen Group Co. Ltd
Foodchem International Corp
Hubei Yitai Pharmaceutical Co. Ltd
Jungbunzlauer Suisse AG
Merck KGaA
Newseed Chemical Co. Ltd
NutriScience Innovations LLC
Roquette Freres SA
Samex Overseas
Sancai Industry Co. Ltd
Shandong Baisheng Biotechnology Co. Ltd
Shandong Fuyuang Bio Tech Co. Ltd
Shandong Xinhong Pharmaceutical Co. Ltd
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Glucuronolactone Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Glucuronolactone Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Glucuronolactone Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Glucuronolactone Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Glucuronolactone Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Glucuronolactone Market Share (%) By Regions (2021-2032)
Table 12 North America Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Table 15 South America Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Glucuronolactone Revenue (USD Million) By Region (2021-2032)
Table 17 North America Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Table 18 North America Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Table 19 North America Glucuronolactone Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Glucuronolactone Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Glucuronolactone Revenue (USD Million) By Product (2021-2032)
Table 26 South America Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Table 27 South America Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Table 28 South America Glucuronolactone Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Glucuronolactone Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Glucuronolactone Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Glucuronolactone Market Share (%) By Regions (2023)
Figure 6. North America Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 12. France Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 12. China Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 14. India Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Glucuronolactone Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Glucuronolactone Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Glucuronolactone Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Glucuronolactone Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Glucuronolactone Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Glucuronolactone Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Glucuronolactone Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Glucuronolactone Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Glucuronolactone Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Glucuronolactone Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Glucuronolactone Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Glucuronolactone Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Glucuronolactone Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Glucuronolactone Revenue (USD Million) By Product (2021-2032)
By Type
Powder
Liquid
Tablet/Capsule
By Application
Preservatives
Antioxidants
Processing Aids and Additives
Energy Supplements
By End-User
Food and Beverages
Pharmaceuticals
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Glucuronolactone Market Size is valued at $338.4 Million in 2024 and is forecast to register a growth rate (CAGR) of 5.3% to reach $511.5 Million by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Aadhunik Industries, Aceto US LLC, Anhui Fubore Pharmaceutical and Chemical Co. Ltd, Anmol Chemicals Group, Creative Compounds, Fengchen Group Co. Ltd, Foodchem International Corp, Hubei Yitai Pharmaceutical Co. Ltd, Jungbunzlauer Suisse AG, Merck KGaA, Newseed Chemical Co. Ltd, NutriScience Innovations LLC, Roquette Freres SA, Samex Overseas, Sancai Industry Co. Ltd, Shandong Baisheng Biotechnology Co. Ltd, Shandong Fuyuang Bio Tech Co. Ltd, Shandong Xinhong Pharmaceutical Co. Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume